Sai Life Sciences' Boston site designated as co-marketed U.S. execution hub for Mabtech's EYRA platform, bringing high-sensitivity multiplex immune profiling to biopharma and biotech clients across ...
Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...
Multiple independent studies have demonstrated strong correlation between multiplex assay technology and traditional ELISA methods. Importantly, multiplex platforms often exhibit superior sensitivity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results